Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 4c

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q1 EPS of ($0.87), $0.04 better than the analyst estimate of ($0.91). Revenue for the quarter came in at $131 million versus the consensus estimate of $128.07 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.

You May Also Be Interested In

• U.S. economy adds 199,000 jobs in November
• Smartsheet (SMAR) Tops Q3 EPS by 8c; Guides Above Views
• DocuSign Inc. (DOCU) tops consensus earnings, revenue estimates